Cannabis Studies Research Guide: eBooks

Assesses the current state of cannabis laws in the United States in the context of broader discussions about drug policy and advances a framework for future efforts to use cannabis legalization to advance social equity. It describes the racist origins of cannabis criminalization and the ways in which the prosecutors of the War on Drugs have disproportionately harmed people of color. It also offers numerous detailed case studies to identify both the successes and failures of the more recent movement to legalize cannabis at the state level, particularly in terms of their efficacy at using cannabis policy to redress social inequality.

Cannabis has a history of medical use dating back millennia; however, the use of cannabis for medicinal purposes fell out of favor in the middle of the last century. There is currently a renewed interest in the potential medicinal value of this plant, as well as individual compounds produced by Cannabis (as well as synthetic analogs). Currently, nearly 50 countries permit the medical use of cannabis, and over a dozen other countries have legalized cannabis-based products (CBD, Sativex, Dronabinol, etc.) for medical use.

Presents the latest research on cannabinoids for human health, covering topics such as potential emerging therapeutic applications and safety concerns. Not only does this book provide an up-to-date source of information for physicians and scientists, but it also provides insight into the wide range of potential applications for cannabinoids in health care. With this new publication, the medical community will gain a more comprehensive understanding of cannabinoids and their potential applications in human health.

Cannabis sativa has a long history; however, it has not been fully exploited for its beneficial uses. This plant can solve many present challenges, including challenges found in the pharmaceutical and cosmetic industries. Bioprospecting of this very important plant can generate economic upliftment of weaker sections of society and states if properly used under rules and regulations. Cannabis sativa Cultivation, Production, and Applications in Pharmaceuticals and Cosmetics discusses in detail the current research conducted in the area of Cannabis sativa in order to make it more useful and sustainable for the future.

Research on the therapeutic efficacy of cannabinoids has demonstrated that cannabidiol (CBD), either alone or in 1:1 mixtures with delta-9-tetrahydrocannabinol (THC), can effectively treat animals in experimental models of neuroinflammatory, demyelinative, neurodegenerative, neuropsychiatric, and neoplastic diseases. Short-term, small-scale, human cohorts, observational studies, randomized, non-randomized, placebo-controlled, and uncontrolled clinical trials have provided low-certainty and moderate-certainty evidence that medical marijuana can reduce spasticity, neuropathic pain, neuroinflammation, anxiety, sleep disturbance, urinary bladder dysfunction, frequency and duration of seizure, tumor size, and metastasis as well as promote overall cancer survival.

In recent years, the public has become acquainted with the benefits of cannabis following the legalization of the use of cannabis-based products such as medicinal products, skincare and body products, CBD, and other developments. This has resulted in an economically viable industry that requires high-level investigation in order for countries to fully benefit from it. Rapid Innovation and Development in the Global Cannabis Market considers the recent innovations and developments in the global cannabis market, captures the effects of different policies governing the industry, and documents products and processes innovations.

This book highlights empirical evidence on the impact of cannabis on childhood development, from infancy up to young adulthood. With the global movement of more relaxed policies and attitudes towards cannabis use, it is important to understand the risks associated with cannabis on youth development. Bridging the gap between knowledge communications and research literature, this volume translates scientific evidence to highlight the consequences of cannabis exposure on young people's lives.

This book examines the effectiveness of a unique area of patient care, cannabis use in medicine. While many American states have legalized medical marijuana, the FDA still has not approved it as a treatment due to a lack of studies to prove its validity.Countries such as Canada and Uruguay, on the other hand, have legalized cannabis. This book aids in accelerating the medical legitimacy of cannabis through comprehensive coverage of its uses, legality, pharmacology, and potential issues. Organized into three parts, the book begins with topics that function as an introduction to cannabis for medical use, such as patient assessments, the role of genetics, evidence-based therapy reviews, legal aspects, and pharmacology. Subsequent chapters then delve into the practical applications of medical cannabis use, including treatment for gastrointestinal disorders, neurological diseases, rheumatic diseases, and pain management. The book's final section features crucial discussions on the potential complications and adverse events in cannabis use, as well as occupation and pediatric considerations.

Marijuana is the most commonly used psychotropic drug in the United States, after alcohol. With the legalization and decriminalization of cannabis, momentum continues to build and propelled by the reduction of stigma associated to its consumption, there is growing concern regarding the long-term impact on brain function and behavior. Cannabis and the Developing Brain aims to provide comprehensive research on the effects of cannabis during neurodevelopment stages (i.e., perinatal and adolescent ages). This book introduces readers to vivo neural circuits, molecular and cellular mechanisms affected by cannabis exposure during three different temporal windows of brain vulnerability. Second, it offers a unique insight to shared neurobiological features of cannabinoid exposure during different developmental periods. Lastly, Cannabis and the Developing Brain determines the adverse impact of developmental cannabinoid exposure on specific cognition, emotion and behaviors.

A comprehensive review of the scientific literature on the possible benefits of CBD, describing findings from both preclinical and human clinical studies. CBD (cannabidiol), a nonintoxicating compound derived from the cannabis plant, can be found in products ranging from lotion and smoothies to chewable gummies and pet treats. It's been promoted-but not always scientifically validated-as a treatment for medical conditions including psychosis, anxiety, pain, and even cancer. This book by three leading cannabis researchers looks at the science of CBD. It offers a comprehensive review of the scientific literature on the possible benefits of CBD, describing findings from both preclinical and human clinical studies.

This book educates and familiarizes psychiatrists with the impact of cannabis beyond the scope of addiction and ways to effectively discuss the existing literature and knowledge with patients. Cannabis in Psychiatric Practice is organized by clinical setting to help tailor the literature to psychiatrists and other mental health clinicians working in all areas, whether traditional outpatient clinics, emergency departments, inpatient psychiatry or medical units. It helps readers, regardless of their training background, learn about the impact of cannabis on a variety of disorders in a manner adjusted to the unique needs and challenges of their particular treatment settings and patient populations.

The use of cannabinoid-based medicines (CBM), and cannabis in particular, has risen steadily among cancer and palliative care patients over the last few years. This textbook aims to address the multiple challenges facing healthcare providers regarding the use of CBM in this vulnerable patient population. It provides insight into the latest preclinical and clinical data and offers a practical approach on the use of CBM in a rapidly evolving landscape. It answers questions regarding the prescribing process and elucidates controversies regarding cannabis' disease-modifying effects. The first chapters will review basic concepts of the endocannabinoid system and pharmacology of CBM, while focusing more specifically on the unique characteristics of two main cannabinoids: THC and CBD. Indicating which benefits can be expected from using either or both of these compounds, the book then addresses issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patients with polypharmacy and multiple comorbidities.

Marijuana is on everyone's mind. Why do so many people enjoy it? What is it doing in our brains? Is it safe for everyone to use? What should we be telling our children? What are the benefits of medical marijuana? How does CBD live up to its hype? Does marijuana have spiritual power? And with so much conflicting information out there, how do we begin to make up our own minds about cannabis? Marijuana on My Mind is for anyone who has ever experienced the mystique of cannabis or wondered exactly how cannabis works. With over 40 years of clinical experience, Dr Timmen Cermak uses science to make sense of the endless debate between advocates and opponents of cannabis and provides answers to some of the greatest mysteries surrounding marijuana.

This book functions as a clinician's guide to the use of cannabidiol (CBD) in the treatment of mental health conditions. It conveys the scientific evidence of efficacy of CBD as well as THC and addresses the social stigma attached to its medical use. The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions.

The place of cannabis in global drug prohibition is in crisis, opening up new directions for socially engaged cannabis research. The Routledge Handbook of Post-Prohibition Cannabis Research invites readers to explore new landscapes of cannabis research under conditions of legalization with, not after, prohibition: "post-prohibition." The chapters are organized into five multidisciplinary sections: Governance, Public Health, Markets and Society, Ecology and the Environment, and Culture and Social Change. Case studies from the United States, Uruguay, Morocco, and the United Kingdom show readers alternative ways of thinking about human-cannabis relationships that move beyond questions of legality and illegality.

Learn how to get in on the ground floor of the booming cannabis industry with this comprehensive guide Investing in Cannabis: The Next Great Investment Opportunity examines the rapidly expanding world of cannabis investment. Written by a renowned expert in "vice investing," Investing in Cannabis takes an in-depth look at all aspects of publicly traded stocks in the cannabis industry for medical or recreational use, including: CBD / hemp companies Cannabis oil extraction Cannabis cultivation / agriculture companies Biotech / pharmaceutical companies. This book focuses on the status and history of cannabis legalization plus concrete examples that every day investors can use to make intelligent and informed investments in any sector of the modern, legal cannabis industry.

Marijuana is the most widely used illegal drug in the world. Over the past couple of decades, several Western jurisdictions have seen reforms in, or changes to, the way cannabis use is being controlled, departing from traditional approaches of criminal prohibition that have dominated cannabis use control regimes for most of the twentieth century. While reform is stalled at the international level, the last decade has seen an acceleration of legislative and regulatory reforms at the local and national levels, with countries no longer willing to bear the human and financial costs of prohibitive policies.